$Hypofractionation of radiation dose to the prostate does not necessarily imply a greater risk of acute radiation proctitis$

Hypofractionation of radiation dose to the prostate does not necessarily imply a greater risk of acute radiation proctitis

Bibliographic Details
Main Authors:	Gianluca Ferini, Stefano Pergolizzi
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Clinical and Translational Radiation Oncology
Subjects:	Prostate cancer Image guided radiation therapy Gastrointestinal toxicities Genitourinary toxicities Hypofractionated radiotherapy Radiation proctitis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405630823001040

Similar Items

Progress in multidisciplinary treatment of hemorrhagic radiation proctitis
by: Qiulian Li, et al.
Published: (2022-01-01)

Comparative efficacy of oral drugs for chronic radiation proctitis — a systematic review
by: Liangzhe Liu, et al.
Published: (2023-08-01)

Radiation Proctitis and Management Strategies
by: Dushyant Singh Dahiya, et al.
Published: (2022-01-01)

The effectiveness of hyperbaric oxygen therapy for managing radiation-induced proctitis – results of a 10-year retrospective cohort study
by: António Moreira Monteiro, et al.
Published: (2023-08-01)

Effects of Ozonated Olive Oil on Acute Radiation Proctitis in Rats
by: Fatma Ayça Gültekin, et al.
Published: (2013-12-01)

A Retrospective Single-Arm Cohort Study in a Single Center of Radiofrequency Ablation in Treatment of Chronic Radiation Proctitis
by: Chien-En Tang, et al.
Published: (2023-02-01)

Management of radiation-induced proctitis
by: Pejman Porouhan, et al.
Published: (2019-01-01)

Radiation Proctitis: The Potential Role of Hyaluronic Acid in the Prevention and Restoration of Any Damage to the Rectal Mucosa among Prostate Cancer Patients Submitted to Curative External Beam Radiotherapy
by: Gianluca Ferini, et al.
Published: (2021-12-01)

Hypofractionated versus conventional fractionation external beam radiotherapy in intermediate and high risk localized prostate cancer
by: Eileen Samuel, et al.
Published: (2024-02-01)

The role of image-guided radiotherapy in prostate cancer: A systematic review and meta-analysis
by: Shilin Wang, et al.
Published: (2023-01-01)

Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial
by: M.M. Beaudry, et al.
Published: (2023-05-01)

Dosimetric Predictors of Toxicity after Prostate Stereotactic Body Radiotherapy: A Single-Institutional Experience of 145 Patients
by: Kyohei Fujii, et al.
Published: (2023-05-01)

Early and Late Readmissions of Radiation Proctitis in the United States: Are We Getting Better?
by: Dushyant Singh Dahiya, et al.
Published: (2024-01-01)

Endoscopic treatment for chronic radiation proctitis
by: E. A. Grishina, et al.
Published: (2020-12-01)

Transcolonoscopic spraying formalin solution for hemorrhagic radiation proctitis: a retrospective analysis
by: Kun Huang, et al.
Published: (2024-01-01)

Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis
by: F. Sinzabakira, et al.
Published: (2023-05-01)

Treatment-related toxicity using prostate bed versus prostate bed and pelvic lymph node radiation therapy following radical prostatectomy: A national population-based study
by: Arunan Sujenthiran, et al.
Published: (2023-05-01)

Start Early and See Inflammatory; Late, Nothing Save RAVE: How to Appreciate Radiation Proctitis as a Continuum
by: Martin Tobi, et al.
Published: (2023-01-01)

Surgical treatment of rectal bleeding in comorbid patients with chronic radiation proctitis
by: A. Z. Tsitskarava, et al.
Published: (2021-06-01)

A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome
by: Una Ryg, et al.
Published: (2022-04-01)

Hypofractionated Postoperative Radiotherapy in Prostate Cancer with Ialuril Soft Gels®: Toxicity and Efficacy Analysis on a Retrospective Series of 305 Patients
by: Nicosia L, et al.
Published: (2022-09-01)

Hyperbaric Oxygenation in Recurrent Rectal Bleeding in the Background of Radiation Proctitis
by: A. V. Leontev, et al.
Published: (2022-04-01)

Extreme Hypofractionation with SBRT in Localized Prostate Cancer
by: Maria Antonia Gómez-Aparicio, et al.
Published: (2021-08-01)

Retrospective study on the toxicity induced by stereotactic body radiotherapy: overview of the reunion experience on prostate cancer in elderly patients
by: Youssef Slama, et al.
Published: (2024-02-01)

Volumetric Response of Limited Brain Metastatic Disease to Focal Hypofractionated Radiation Therapy
by: Asanka R. Wijetunga, et al.
Published: (2021-11-01)

Argon plasma coagulation for the treatment of chronic radiation proctitis – real-world data from Indonesian National Cancer Center
by: Lianda Siregar, et al.
Published: (2021-09-01)

Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation Treatment
by: Fiorella D’Auria, et al.
Published: (2022-06-01)

Stereotactic Radiation Therapy versus Brachytherapy: Relative Strengths of Two Highly Efficient Options for the Treatment of Localized Prostate Cancer
by: Manon Kissel, et al.
Published: (2022-04-01)

Dosimetric Comparison of Ultra-Hypofractionated and Conventionally Fractionated Radiation Therapy Boosts for Patients with High-Risk Prostate Cancer
by: Tomasz Piotrowski, et al.
Published: (2022-03-01)

Malignant Pleural Mesothelioma: Preliminary Toxicity Results of Adjuvant Radiotherapy Hypofractionation in a Prospective Trial (MESO-RT)
by: Elisabetta Parisi, et al.
Published: (2023-02-01)

Intrafraction Prostate Motion Management for Ultra-Hypofractionated Radiotherapy of Prostate Cancer
by: Christoph Oehler, et al.
Published: (2022-08-01)

Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
by: Pedro C. Lara, et al.
Published: (2022-07-01)

An Oligomeric Sulfated Hyaluronan and Silk-Elastinlike Polymer Combination Protects against Murine Radiation Induced Proctitis
by: Douglas Steinhauff, et al.
Published: (2022-01-01)

Development and validation of an interpretable radiomic nomogram for severe radiation proctitis prediction in postoperative cervical cancer patients
by: Chaoyi Wei, et al.
Published: (2023-01-01)

HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial
by: Budhi Singh Yadav, et al.
Published: (2024-01-01)

Evaluation of T2-Weighted MRI for Visualization and Sparing of Urethra with MR-Guided Radiation Therapy (MRgRT) On-Board MRI
by: Jonathan Pham, et al.
Published: (2021-07-01)

Five-Fraction Stereotactic Radiotherapy for Brain Metastases—A Retrospective Analysis
by: Julian P. Layer, et al.
Published: (2023-01-01)

Adaptive ultra‐hypofractionated whole‐pelvic radiotherapy in high‐risk and very high‐risk prostate cancer on 1.5‐Tesla MR‐Linac: Estimated delivered dose and early toxicity results
by: Linrui Gao, et al.
Published: (2024-03-01)

Correlation between biological effective dose and radiation-induced liver disease from hypofractionated radiotherapy
by: Angelo M Bergamo, et al.
Published: (2019-01-01)

Preliminary results of hypofractionated radiotherapy in breast cancer in Chandigarh, India: single-centre, non-inferiority, open-label, randomised, phase 3 trialResearch in context
by: Budhi Singh Yadav, et al.
Published: (2024-05-01)